17 , 18 , 19 A convincingly better understanding of the role of PGC‐1α in variant tumour types will be highly significant in exploring whether this target will be amenable as anticancer agents in ccRCCs.
← all excerpts
N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1α signalling axis.
1
—
—